150 related articles for article (PubMed ID: 30702862)
1. Metabolic Discrimination of Breast Cancer Subtypes at the Single-Cell Level by Multiple Microextraction Coupled with Mass Spectrometry.
Wang R; Zhao H; Zhang X; Zhao X; Song Z; Ouyang J
Anal Chem; 2019 Mar; 91(5):3667-3674. PubMed ID: 30702862
[TBL] [Abstract][Full Text] [Related]
2. Implementing a central composite design for the optimization of solid phase microextraction to establish the urinary volatomic expression: a first approach for breast cancer.
Silva CL; Perestrelo R; Silva P; Tomás H; Câmara JS
Metabolomics; 2019 Apr; 15(4):64. PubMed ID: 30997581
[TBL] [Abstract][Full Text] [Related]
3. SPME-LC/MS-based serum metabolomic phenotyping for distinguishing ovarian cancer histologic subtypes: a pilot study.
Olkowicz M; Rosales-Solano H; Kulasingam V; Pawliszyn J
Sci Rep; 2021 Nov; 11(1):22428. PubMed ID: 34789766
[TBL] [Abstract][Full Text] [Related]
4. Metabolic profiling of breast cancer: Differences in central metabolism between subtypes of breast cancer cell lines.
Willmann L; Schlimpert M; Halbach S; Erbes T; Stickeler E; Kammerer B
J Chromatogr B Analyt Technol Biomed Life Sci; 2015 Sep; 1000():95-104. PubMed ID: 26218769
[TBL] [Abstract][Full Text] [Related]
5. Human plasma metabolomics for identifying differential metabolites and predicting molecular subtypes of breast cancer.
Fan Y; Zhou X; Xia TS; Chen Z; Li J; Liu Q; Alolga RN; Chen Y; Lai MD; Li P; Zhu W; Qi LW
Oncotarget; 2016 Mar; 7(9):9925-38. PubMed ID: 26848530
[TBL] [Abstract][Full Text] [Related]
6. Solid phase microextraction, mass spectrometry and metabolomic approaches for detection of potential urinary cancer biomarkers--a powerful strategy for breast cancer diagnosis.
Silva CL; Passos M; Câmara JS
Talanta; 2012 Jan; 89():360-8. PubMed ID: 22284503
[TBL] [Abstract][Full Text] [Related]
7. Volatile metabolomic signature of bladder cancer cell lines based on gas chromatography-mass spectrometry.
Rodrigues D; Pinto J; Araújo AM; Monteiro-Reis S; Jerónimo C; Henrique R; de Lourdes Bastos M; de Pinho PG; Carvalho M
Metabolomics; 2018 Apr; 14(5):62. PubMed ID: 30830384
[TBL] [Abstract][Full Text] [Related]
8. Advances in mass spectrometry based single-cell metabolomics.
Duncan KD; Fyrestam J; Lanekoff I
Analyst; 2019 Jan; 144(3):782-793. PubMed ID: 30426983
[TBL] [Abstract][Full Text] [Related]
9. Systematic evaluation of solid-phase microextraction coatings for untargeted metabolomic profiling of biological fluids by liquid chromatography-mass spectrometry.
Vuckovic D; Pawliszyn J
Anal Chem; 2011 Mar; 83(6):1944-54. PubMed ID: 21332182
[TBL] [Abstract][Full Text] [Related]
10. Label-free Mass Cytometry for Unveiling Cellular Metabolic Heterogeneity.
Yao H; Zhao H; Zhao X; Pan X; Feng J; Xu F; Zhang S; Zhang X
Anal Chem; 2019 Aug; 91(15):9777-9783. PubMed ID: 31242386
[TBL] [Abstract][Full Text] [Related]
11. Live Single-Cell Mass Spectrometry (LSC-MS) for Plant Metabolomics.
Masuda K; Abouleila Y; Ali A; Yanagida T; Masujima T
Methods Mol Biol; 2018; 1778():269-282. PubMed ID: 29761445
[TBL] [Abstract][Full Text] [Related]
12. RRLC-MS/MS-based metabonomics combined with in-depth analysis of metabolic correlation network: finding potential biomarkers for breast cancer.
Chen Y; Zhang R; Song Y; He J; Sun J; Bai J; An Z; Dong L; Zhan Q; Abliz Z
Analyst; 2009 Oct; 134(10):2003-11. PubMed ID: 19768207
[TBL] [Abstract][Full Text] [Related]
13. Direct metabolomics for plant cells by live single-cell mass spectrometry.
Fujii T; Matsuda S; Tejedor ML; Esaki T; Sakane I; Mizuno H; Tsuyama N; Masujima T
Nat Protoc; 2015 Sep; 10(9):1445-56. PubMed ID: 26313480
[TBL] [Abstract][Full Text] [Related]
14. A plasma metabolite panel as biomarkers for early primary breast cancer detection.
Yuan B; Schafferer S; Tang Q; Scheffler M; Nees J; Heil J; Schott S; Golatta M; Wallwiener M; Sohn C; Koal T; Wolf B; Schneeweiß A; Burwinkel B
Int J Cancer; 2019 Jun; 144(11):2833-2842. PubMed ID: 30426507
[TBL] [Abstract][Full Text] [Related]
15. High-Throughput Solid-Phase Microextraction-Liquid Chromatography-Mass Spectrometry for Microbial Untargeted Metabolomics.
Mousavi F; Bojko B; Pawliszyn J
Methods Mol Biol; 2019; 1859():133-152. PubMed ID: 30421227
[TBL] [Abstract][Full Text] [Related]
16. Mass spectrometry-based metabolomics: applications to biomarker and metabolic pathway research.
Zhang A; Sun H; Yan G; Wang P; Wang X
Biomed Chromatogr; 2016 Jan; 30(1):7-12. PubMed ID: 25739660
[TBL] [Abstract][Full Text] [Related]
17. Novel personalized pathway-based metabolomics models reveal key metabolic pathways for breast cancer diagnosis.
Huang S; Chong N; Lewis NE; Jia W; Xie G; Garmire LX
Genome Med; 2016 Mar; 8(1):34. PubMed ID: 27036109
[TBL] [Abstract][Full Text] [Related]
18. Breast cancer detection using targeted plasma metabolomics.
Jasbi P; Wang D; Cheng SL; Fei Q; Cui JY; Liu L; Wei Y; Raftery D; Gu H
J Chromatogr B Analyt Technol Biomed Life Sci; 2019 Jan; 1105():26-37. PubMed ID: 30562627
[TBL] [Abstract][Full Text] [Related]
19. Ten Major Future Challenges in Single-Cell Metabolomics.
Shrestha B
Methods Mol Biol; 2020; 2064():219-223. PubMed ID: 31565777
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
